FDA grants full approval to Pfizer’s COVID-19 vaccine for 12-15 age group

Jul 08, 2022 - 04:02 PM
FDAapproval

The Food and Drug Administration today granted full approval of Pfizer’s COVID-19 vaccine for young teens, covering the age group spanning 12 to 15 years old. FDA said the vaccine, which has been administered in two-dose regimens to nearly 9 million Americans, earned full approval following its “rigorous analysis and evaluation of the safety and effectiveness data.” The approval does not apply to booster doses for that age group. 

Related News Articles

Headline
FDA issues updated EUA for bivalent booster doses to fight omicron; providers to cease administration of monovalent boosters
The Food and Drug Administration yesterday announced it has amended the emergency use authorizations for Pfizer’s and Moderna’s COVID-19 vaccines to…
Headline
Pfizer applies for EUA for variant-tailored booster; unveils new efficacy data for youngest children
Pfizer yesterday announced its application for an emergency use authorization for a COVID-19 vaccine booster that is designed to protect against the SARS-CoV-2…
Headline
FDA expands Novavax EUA to include children 12 and older
Novavax today announced the Food and Drug Administration expanded the emergency use authorization for its Adjuvanted (NVX-CoV2373) COVID-19 vaccine. Under…
Headline
CMS fact sheets summarize status of Medicare COVID-19 waivers
The Centers for Medicare & Medicaid Services yesterday released fact sheets summarizing the current status of Medicare COVID-19 blanket waivers and…
Headline
Hospital COVID-19 data reporting transitioning to CDC in mid-December
In mid-December, hospitals will transition to reporting COVID-19 data via the Centers for Disease Control and Prevention’s National Healthcare Safety Network,…
Headline
FDA recommends repeating COVID-19 at-home test in 48 hours if negative
The Food and Drug Administration yesterday advised people who get a negative result from an at-home COVID-19 antigen test to test themselves again after…